An open label trial of anakinra to prevent respiratory failure in COVID-19
- National and Kapodistrian University of Athens, Medical School, Greece
- Democritus University of Thrace, Medical School, Greece
- Aristotle University of Thessaloniki, Medical School, Greece
- National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, Greece
- Univeristy of Ioannina School of Medicine, Greece
- University of Ioannina, School of Health Sciences, Faculty of Medicine, Greece
- General Hospital of Kerkyra, Greece
- University of Patras, Greece
- Radboud University Medical Centre, Netherlands
- Copenhagen University Hospital Hvidovre, Denmark
- Radboud University Nijmegen Medical Centre, Netherlands
Additional files
-
All additional files
Any figure supplements, source code, source data, videos or supplementary files associated with this article are contained within this zip.
- https://cdn.elifesciences.org/articles/66125/elife-66125-supp-v1.zip
Download links
A two-part list of links to download the article, or parts of the article, in various formats.
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
An open label trial of anakinra to prevent respiratory failure in COVID-19
eLife 10:e66125.
https://doi.org/10.7554/eLife.66125
